159 related articles for article (PubMed ID: 30781383)
1. Design and Evaluation of An Extended-Release Olmesartan Tablet Using Chitosan/Cyclodextrin Composites.
Anraku M; Tabuchi R; Goto M; Iohara D; Mizukai Y; Maezaki Y; Michihara A; Kadowaki D; Otagiri M; Hirayama F
Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30781383
[TBL] [Abstract][Full Text] [Related]
2. Slow-release of famotidine from tablets consisting of chitosan/sulfobutyl ether β-cyclodextrin composites.
Anraku M; Hiraga A; Iohara D; Pipkin JD; Uekama K; Hirayama F
Int J Pharm; 2015 Jun; 487(1-2):142-7. PubMed ID: 25882010
[TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CD.
Okimoto K; Ohike A; Ibuki R; Aoki O; Ohnishi N; Irie T; Uekama K; Rajewski RA; Stella VJ
Pharm Res; 1999 Apr; 16(4):549-54. PubMed ID: 10227711
[TBL] [Abstract][Full Text] [Related]
4. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
[TBL] [Abstract][Full Text] [Related]
5. Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent.
Rao VM; Haslam JL; Stella VJ
J Pharm Sci; 2001 Jul; 90(7):807-16. PubMed ID: 11458330
[TBL] [Abstract][Full Text] [Related]
6. Inclusion Complex of Docetaxel with Sulfobutyl Ether β-Cyclodextrin: Preparation, In Vitro Cytotoxicity and In Vivo Safety.
Ren L; Yang X; Guo W; Wang J; Chen G
Polymers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066097
[TBL] [Abstract][Full Text] [Related]
7. Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-beta-CD.
Okimoto K; Miyake M; Ohnishi N; Rajewski RA; Stella VJ; Irie T; Uekama K
Pharm Res; 1998 Oct; 15(10):1562-8. PubMed ID: 9794499
[TBL] [Abstract][Full Text] [Related]
8. Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-beta-cyclodextrin as both a solubilizing and an osmotic pump agent.
Okimoto K; Rajewski RA; Stella VJ
J Control Release; 1999 Mar; 58(1):29-38. PubMed ID: 10021487
[TBL] [Abstract][Full Text] [Related]
9. Chloramphenicol/sulfobutyl ether-β-cyclodextrin complexes in an ophthalmic delivery system: prolonged residence time and enhanced bioavailability in the conjunctival sac.
Xu Y; Zhang C; Zhu X; Wang X; Wang H; Hu G; Fu Q; He Z
Expert Opin Drug Deliv; 2019 Jun; 16(6):657-666. PubMed ID: 31033370
[No Abstract] [Full Text] [Related]
10. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides.
Trapani A; Lopedota A; Franco M; Cioffi N; Ieva E; Garcia-Fuentes M; Alonso MJ
Eur J Pharm Biopharm; 2010 May; 75(1):26-32. PubMed ID: 20102738
[TBL] [Abstract][Full Text] [Related]
11. Thermosensitive
Gözcü S; Polat KH
Turk J Pharm Sci; 2023 May; 20(2):78-83. PubMed ID: 37161283
[TBL] [Abstract][Full Text] [Related]
12. Biomaterials based on freeze dried surface-deacetylated chitin nanofibers reinforced with sulfobutyl ether β-cyclodextrin gel in wound dressing applications.
Tabuchi R; Azuma K; Izumi R; Tanou T; Okamoto Y; Nagae T; Iohara D; Uekama K; Otagiri M; Hirayama F; Ifuku S; Anraku M
Int J Pharm; 2016 Sep; 511(2):1080-7. PubMed ID: 27521704
[TBL] [Abstract][Full Text] [Related]
13. Inclusion Complex of Isoliquiritigenin With Sulfobutyl Ether-β-Cyclodextrin: Preparation, Characterization, Inclusion Mode, Solubilization, and Stability.
Wu X; Li J; Hu C; Zheng Y; Zhang Y; Li J; Li M; Xiao D; Lu L; Huang Y; Zhang X; Li C
Front Chem; 2022; 10():930297. PubMed ID: 35800032
[TBL] [Abstract][Full Text] [Related]
14. Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion.
Fukuda M; Miller DA; Peppas NA; McGinity JW
Int J Pharm; 2008 Feb; 350(1-2):188-96. PubMed ID: 17920217
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of stereoselective dissolution of racemic salbutamol matrices prepared with commonly used excipients and 1H-NMR study.
Srichana T; Suedee R
Drug Dev Ind Pharm; 2001 May; 27(5):457-64. PubMed ID: 11448053
[TBL] [Abstract][Full Text] [Related]
16. Optimization of sulfobutyl-ether-β-cyclodextrin levels in oral formulations to enhance progesterone bioavailability.
Shankar VK; Police A; Pandey P; Cuny ZG; Repka MA; Doerksen RJ; Murthy SN
Int J Pharm; 2021 Mar; 596():120212. PubMed ID: 33493605
[TBL] [Abstract][Full Text] [Related]
17. Drug-in-cyclodextrin-in-polymeric nanoparticles: A promising strategy for rifampicin administration.
Abruzzo A; Croatti V; Zuccheri G; Pasquale Nicoletta F; Sallustio V; Corazza E; Vitali B; Cerchiara T; Luppi B; Bigucci F
Eur J Pharm Biopharm; 2022 Nov; 180():190-200. PubMed ID: 36210035
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery.
Zhang P; Liu X; Hu W; Bai Y; Zhang L
Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746
[TBL] [Abstract][Full Text] [Related]
19. Development and physicochemical characterization of chitosan hydrochloride/sulfobutyl ether-β-cyclodextrin nanoparticles for cinnamaldehyde entrapment.
Zhu W; Wu J; Guo X; Sun X; Li Q; Wang J; Chen L
J Food Biochem; 2020 Jun; 44(6):e13197. PubMed ID: 32189350
[TBL] [Abstract][Full Text] [Related]
20. Effect of sulfobutyl ether-β-cyclodextrin and propylene glycol alginate on the solubility of clozapine.
Furuishi T; Sekino K; Gunji M; Fukuzawa K; Nagase H; Endo T; Ueda H; Yonemochi E
Pharm Dev Technol; 2019 Apr; 24(4):479-486. PubMed ID: 30126299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
